Whitepaper
6 Sep 2019

Editorial in OndrugDevelopment in the Ophthalmic Issue January 2019

PDF 678 kB

An ageing population, high computer and mobile device use and increasing pollution and allergies are all contributing to a greater global demand for eyedrops. At the same time, the move towards preservative-free formulations is driving the development of novel ophthalmic devices. Thomas Grinnan, Vice-President, Sales & Marketing, Healthcare, and Ralf Hergenröther, Product Line Manager, Healthcare Solutions, both of Silgan Dispensing Systems, explain how extensive market research and consumer testing led to the development of an eyedropper that meets patients’ and physicians’ needs for an easy-to-use device, which offers precise dosing andanti-microbial integrity.

Content provided by our supplier

Silgan Dispensing Systems

  • US
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator

Other Content from Silgan Dispensing Systems (4)